Arne Hauge joins Bio-Works as Chief Financial Officer
Bio-Works announces today that Arne Hauge has joined the company as Chief Financial Officer. He is joining as a member of Bio-Works executive team and will report directly to CEO, Jonathan Royce.
As CFO at Bio-Works Arne Hauge will be responsible for financial management of the company, including leadership of the company’s planning processes, and he will work together with management team to drive Bio-Works to the next stage of growth.
Arne Hauge’s latest position was with Felestad Trading AB, as Interim CFO. Arne is a business driven and strategic CFO, with experience from two start-ups - Halebop in Sweden and Yoigo in Spain. During the last two decades at Telia Company AB, he has held various roles, including Investment Manager, CFO, COO, CCO, Strategy & Business Development and M&A.
Arne has a long history of working with international businesses. Prior to Telia Company AB, he worked for the chemical company AGA AB, with Financial and Business Control, within Region Latin America and Region Eastern Europe, including two years working in Caracas, Venezuela. Arne has a combination of skills from the start-up and scale-up world, but also solid experience in the area of change management.
“I see that Bio-Works has an exciting international expansion ahead. Bio-Works has already built a solid platform and product portfolio within the area of chromatography resins. I am proud to be part of the team and excited to drive Bio-Works through the scale-up phase towards profitability. I’m very impressed over all the competent people that we have in the company, and I am happy to be part of the Bio-Works family!” said Arne Hauge, CFO, Bio-Works.
“Arne is a strategic and multi-faceted CFO with an impressive background and leadership profile that he can leverage to lead all aspects of finance at Bio-Works. His deep experience from manufacturing companies and start-ups is an ideal fit for our next chapter at Bio-Works. We look forward to working together to drive Bio-Works through the next growth phase and to profitability,”
said Jonathan Royce, CEO, Bio-Works.
Arne started his position as CFO at Bio-Works on August 1, 2023.
Contacts
For more information, please visit the Bio-Works homepage at,www.bio-works.comor contact: Jonathan Royce, CEO, e-mail:jonathan.royce@bio-works.com, phone: +46 70 1434143.
About Bio-Works
Bio-Works enables scientists to achieve their purification goals, from laboratory research to large scale bioprocess production. Our vision is a biotech industry that embraces, develops and builds on new methods and novel ideas. WorkBeads™, Bio-Works’ next-generation, agarose-based products, are used to purify proteins, peptides and other biomolecules, resulting in purer therapies and safer diagnostics. Through collaboration with customers and partners, we develop purification solutions that make important medicines available and accessible to everyone.
Bio-Works’ headquarters, with R&D and manufacturing, is located in Uppsala Business Park in Uppsala, Sweden. We supply products globally, through a combination of direct sales and via distributors in Europe, North America and Asia. The company is certified according to the ISO 9001:2015 quality management system. Bio-Works is listed on Nasdaq First North (“BIOWKS”), and FNCA Sweden AB, +46 (0) 8-528 00 399,info@fnca.se, is appointed Certified Adviser. For more information,www.bio-works.com.
